Accenture Investing Cash Flow decreased by 244.8% to -$1.74B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 327.4%, from -$407.28M to -$1.74B. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -17.3% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$572.69M | -$2.85B | -$1.91B | -$272.50M | -$666.95M | -$1.41B | -$782.07M | -$478.30M | $0.00 | -$1.37B | -$855.43M | -$2.21B | -$2.45B | -$1.55B | -$385.52M | -$407.28M | -$455.55M | -$771.29M | -$504.88M | -$1.74B |
| QoQ Change | — | -397.9% | +32.9% | +85.8% | -144.8% | -111.2% | +44.5% | +38.8% | +100.0% | — | +37.4% | -158.1% | -11.0% | +36.9% | +75.1% | -5.6% | -11.9% | -69.3% | +34.5% | -244.8% |
| YoY Change | — | — | — | — | -16.5% | +50.6% | +59.1% | -75.5% | +100.0% | +2.9% | -9.4% | -361.7% | — | -13.2% | +54.9% | +81.6% | +81.4% | +50.1% | -31.0% | -327.4% |